View in EDS HTML Full Text PDF Full Text

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients.

Saved in:
Bibliographic Details
Title: Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients.
Authors: Barbier, François1,2 (AUTHOR) francois.barbier@chr-orleans.fr, Hraiech, Sami3 (AUTHOR), Kernéis, Solen4 (AUTHOR), Veluppillai, Nathanaël4 (AUTHOR), Pajot, Olivier5 (AUTHOR), Poissy, Julien6 (AUTHOR), Roux, Damien2,7 (AUTHOR), Zahar, Jean-Ralph2,8 (AUTHOR)
Source: Annals of Intensive Care. 7/18/2023, Vol. 13 Issue 1, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21105820
DOI:10.1186/s13613-023-01153-6